Send the following on WhatsApp
Continue to Chathttps://de.marketscreener.com/kurs/aktie/ONCOTELIC-THERAPEUTICS-IN-120975745/news/Oncotelic-Therapeutics-erhalt-FDA-Zulassung-fur-klinische-Phase-2-Studie-der-Kombination-OT-101-Pe-40552448/?utm_source=whatsapp&utm_medium=social&utm_campaign=share